Basic Stats
| CIK | 1848861 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Healthcare AI Acquisition Corp. - Equity Warrant
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| September 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| August 20, 2025 |
EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| August 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2025 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporatio |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001- 41145 G4373K109 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41145 HEALTHCAR |
|
| June 5, 2025 |
EXHIBIT 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman Healthcare AI Acquisition Corp. (ROC #371585) (the "Company") TAKE NOTICE that at an Extraordinary General Meeting of the Company held virtually on 30 April 2025, the following special resolution was passed: 1. The Extension Amendment Proposal “RESOLVED, as a special resolution, THAT: Th |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 30, 2025 (May 28, 2025) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of |
|
| May 30, 2025 |
A&R Promissory Note dated May 28, 2025 EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001- 41145 CUSIP NUMBER G4373K109 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Trans |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2025 (April 30, 2025) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 17, 2025 (April 14, 2025) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction |
|
| April 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| April 7, 2025 |
EXHIBIT 99.1 |
|
| April 7, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 7, 2025 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporation) |
|
| April 7, 2025 |
Filed by Leading Partners Limited pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Healthcare AI Acquisition Corp. Commission File No.: 001-41145 |
|
| March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 20, 2025 (March 14, 2025) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HEALTHCARE AI ACQUISITION CORP. (Exact Name of Regi |
|
| March 3, 2025 |
EXHIBIT 21 None |
|
| March 3, 2025 |
Description of Registrant’s Securities. EXHIBIT 4.2 DESCRIPTION OF SECURITIES OF HAIA The following description of the material terms of the securities of Healthcare AI Acquisition Corp. (“we,” “us,” “our” “HAIA” or “the company”) is not intended to be a complete summary of the rights and preferences of such securities and is subject to and qualified by reference to HAIA’s amended and restated memorandum and articles of association. A c |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2025 (February 14, 2025) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisd |
|
| January 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 23, 2025 (January 17, 2025) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdic |
|
| January 23, 2025 |
Promissory Note dated January 17, 2025 EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| January 14, 2025 |
EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| January 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 14, 2025 (January 13, 2025) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdic |
|
| December 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 20, 2024 (December 18, 2024) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisd |
|
| December 20, 2024 |
Amended and Restated Promissory Note dated December 18, 2024 EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| December 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 12, 2024 (December 10, 2024) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisd |
|
| December 6, 2024 |
HAIA / Healthcare AI Acquisition Corp. / Meteora Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| December 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41145 HEALT |
|
| November 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 27, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporat |
|
| November 27, 2024 |
Promissory Note dated November 21, 2024 EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| November 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001- 41145 G4373K109 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ T |
|
| November 14, 2024 |
HAIA / Healthcare AI Acquisition Corp. / Meteora Capital, LLC Passive Investment SC 13G 1 meteorahaia09302024.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Healthcare AI Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G4373K109 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this St |
|
| November 6, 2024 |
Investor Presentation Deck 2024 EXHIBIT 99.1 |
|
| November 6, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporati |
|
| November 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| November 1, 2024 |
Julia Aryeh Senior Counsel 345 Park Avenue New York, NY 10154 Direct 212.407.4043 Main 212.407.4000 Fax 212.937.3943 [email protected] Via Edgar November 1, 2024 Ronald E. Alper and Pam Howell U.S. Securities & Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Re: Healthcare AI Acquisition Corp. Revised Preliminary Proxy |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| November 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| October 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.2) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HEALTHCARE AI ACQUISITION CORP. |
|
| October 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| October 3, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 2, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporatio |
|
| October 3, 2024 |
Investor Presentation Deck 2024 with Appendix EXHIBIT 99.1 |
|
| September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41145 HEALTHCARE |
|
| August 26, 2024 |
Promissory Note, dated August 23, 2024 EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| August 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporatio |
|
| August 16, 2024 |
EXHIBIT 10.3 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is dated as of , 2024, by and among the undersigned (the “Holder”) and Leading Partners Limited, a Cayman Islands exempted company (“Holdco”). Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Business Combination Agreement (as defined below). BACKGROUND A. Leading |
|
| August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 15, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporatio |
|
| August 16, 2024 |
EXHIBIT 10.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of ☑, 2024, is made and entered into by and among Leading Partners Limited, a Cayman Islands exempted company (the “Company”), Leading Group Limited, a Cayman Islands exempted company(“Leading Group”), Healthcare AI Acquisition Corp., a Cayman Islands |
|
| August 16, 2024 |
EXHIBIT 99.1 Leading Group, an Insurance Channel Specialist in China, to be Publicly Listed through a Merger with Healthcare AI Acquisition Corp. (NASDAQ: HAIA) BEIJING, China and NEW YORK NY, August 15, 2024 – Leading Group Limited (“LEADING”), a licensed digital insurance broker operating in the Insurance Services segment in China as an Insurance Channel Specialist, and Healthcare AI Acquisition |
|
| August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41145 HEALTHC |
|
| August 16, 2024 |
EXHIBIT 2.1 Execution Copy BUSINESS COMBINATION AGREEMENT by and among AGREEMENT AND PLAN OF MERGER by and among LEADING PARTNERS LIMITED, HEALTHCARE AI ACQUISITION CORP. and LEADING GROUP LIMITED dated as of August 15, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS; CONSTRUCTION 3 1.1 Definitions 3 1.2 Construction 21 ARTICLE II TRANSACTIONS; CLOSING 22 2.1 Pre-Closing Actions 22 2.2 The Compa |
|
| August 16, 2024 |
Company Shareholder Support Agreement dated as of August 15, 2024 EXHIBIT 10.2 COMPANY SHAREHOLDER SUPPORT AGREEMENT COMPANY SHAREHOLDER SUPPORT AGREEMENT dated as of August 15 2024 (this “Support Agreement”), by and among the shareholders listed on Exhibit A hereto (each, a “Shareholder”), Leading Group Limited, a Cayman Islands exempted company with limited liability (the “Company”), and Healthcare AI Acquisition Corp., a Cayman Islands exempted company with l |
|
| August 16, 2024 |
SPAC Shareholder Support Agreement dated as of August 15, 2024 EXHIBIT 10.1 SPAC SHAREHOLDER SUPPORT AGREEMENT SPAC SHAREHOLDER SUPPORT AGREEMENT dated as of August 15, 2024 (this “Agreement”), by and among Healthcare AI Acquisition, LLC and Atticus Ale, LLC (each of Healthcare AI Acquisition, LLC and Atticus Ale, LLC, a “Shareholder”), Leading Group Limited, a Cayman Islands exempted company with limited liability (the “Company”), and Healthcare AI Acquisiti |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001- 41145 G4373K109 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41145 HEALTHCAR |
|
| July 19, 2024 |
Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter EXHIBIT 99.1 Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter New York July 19, 2024 (NEWSWIRE) - Healthcare AI Acquisition Corp. (NASDAQ: HAIA, the “Company”), a special purpose acquisition company, announced today that it received a notification letter from The Nasdaq Stock Market (“Nasdaq”) that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as it had |
|
| July 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 15, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporation) |
|
| June 13, 2024 |
Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 13, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporation) |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001- 41145 G4373K109 CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☒ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Trans |
|
| May 13, 2024 |
Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 13, 2024 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporation) |
|
| April 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HEALTHCARE AI ACQUISITION CORP. |
|
| April 24, 2024 |
EXHIBIT 97.1 HEALTHCARE AI ACQUISITION CORP. CLAWBACK POLICY Introduction The Board of Directors (the “Board”) of Healthcare AI Acquisition Corp. (the “Company”) believes that it is in the best interests of the Company and its stockholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The |
|
| April 17, 2024 |
EXHIBIT 97.1 HEALTHCARE AI ACQUISITION CORP. CLAWBACK POLICY Introduction The Board of Directors (the “Board”) of Healthcare AI Acquisition Corp. (the “Company”) believes that it is in the best interests of the Company and its stockholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The |
|
| April 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to HEALTHCARE AI ACQUISITION CORP. (Exact Name of Regi |
|
| March 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001- 41145 G4373K109 CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| February 13, 2024 |
SC 13G 1 d767886dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G4373K109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the Appropri |
|
| February 12, 2024 |
KYG4373K1094 / Healthcare AI Acquisition Corp. / ARISTEIA CAPITAL LLC Passive Investment SC 13G/A 1 formhealthcareaisc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Under the Securities Exchange Act of 1934 (Amendment No. 1) Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 (Title of Class of Securities) G4373K109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing |
|
| February 12, 2024 |
SC 13G/A 1 ea193068-13ga2cantorhealth.htm AMENDMENT NO. 2 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 2)* Under the Securities Exchange Act of 1934 Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Titles of Class of Securities) G4373K109 (CUSIP Number) December 31, 2023 (Da |
|
| February 12, 2024 |
Joint Filing Agreement, dated as of February 12, 2024, by and among the Reporting Persons EX-99.1 2 ea193068ex99-1healthcare.htm JOINT FILING AGREEMENT, DATED AS OF FEBRUARY 12, 2024, BY AND AMONG THE REPORTING PERSONS EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached |
|
| February 8, 2024 |
SC 13G/A 1 formsc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Healthcare AI Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) G4373K125 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Ch |
|
| January 19, 2024 |
SC 13G/A 1 p24-0187sc13ga.htm HEALTHCARE AI ACQUISITION CORP. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value per share (Title of Class of Securities) G4373K109 (CUSIP Number) December 31, 2023 (Date of event which require |
|
| December 28, 2023 |
SC 13D 1 haiasc13d.htm SC 13D SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 Healthcare AI Acquisition Corp (Name of Issuer) Class A Ordinary Shares, $0.0001 par value (Title of Class of Securi |
|
| December 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 28, 2023 (December 28, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisd |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14F-1 Information Statement Pursuant to Section 14(f) of the Securities Exchange Act of 1934 and Rule 14f-1 Thereunder Healthcare AI Acquisition Corp. (Exact Name of Registrant as Specified in its Charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporation) (Commission File Number) (I.R. |
|
| December 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41145 HEALT |
|
| September 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 8, 2023 (September 5, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisd |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 17, 2023 (August 11, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdicti |
|
| August 17, 2023 |
EXHIBIT 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman Healthcare AI Acquisition Corp. (ROC#371585) (the "Company") TAKE NOTICE that at an Extraordinary General Meeting of the Company held virtually on 11 August 2023, the following special resolutions were passed: The Extension Amendment Proposal “RESOLVED, as a special resolution, THAT: The |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| August 8, 2023 |
EXHIBIT 10.1 NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST This Non-Redemption Agreement and Assignment of Economic Interest (this “Agreement”) is entered as of August [*], 2023 by and among Healthcare AI Acquisition Corp. (“HAIA”), Atticus Ale, LLC, a limited liability company (the “Sponsor”) and the undersigned investors (collectively, the “Investor”). RECITALS WHEREAS, the Sponso |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41145 HEALTHCARE |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2023 (August 7, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| July 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| July 14, 2023 |
EXHIBIT 16.1 July 14, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Healthcare AI Acquisition Corp. under Item 4.01 of its Form 8-K/A dated July 14, 2023. We agree with the statements concerning our Firm in such Form 8-K/ A; we are not in a position to agree or disagree with other statements of Healthcare AI Acqui |
|
| July 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 14, 2023(July 5, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or ot |
|
| July 13, 2023 |
EXHIBIT 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATI |
|
| July 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 13, 2023 (July 12, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction o |
|
| July 13, 2023 |
EXHIBIT 99.1 Healthcare AI Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination New York July 12, 2023 (NEWSWIRE) - Healthcare AI Acquisition Corp. (NASDAQ: HAIA, the “Company”), a special purpose acquisition company, announced today that Atticus Ale, LLC, the Company’s sponsor (“Sponsor”), has deposited into the Company’s trust a |
|
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 11, 2023 (July 5, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of |
|
| July 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 3, 2023 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of incorporation) |
|
| June 14, 2023 |
EXHIBIT 10.1 EXECUTION DRAFT SHARE PURCHASE AGREEMENT by and among HEALTHCARE AI ACQUISITION LLC the Sponsor on the one hand as Seller ATTICUS ALE, LLC on the other hand as Buyer and HEALTHCARE AI ACQUISITION CORP. Dated: June 8, 2023 This document is intended solely to facilitate discussions among the parties identified herein. It is not intended to create, and it will not be deemed to create, a |
|
| June 14, 2023 |
EXHIBIT 10.4 POWER OF ATTORNEY AND IRREVOCABLE PROXY Dated June 12, 2023 I or We, HEALTHCARE AI ACQUISITION LLC (as the "Principal"), the holder of 2,105,770 Class B ordinary shares, par value US$0.0001 per share (the “Shares”) in the capital of Healthcare AI Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands with registration number 371585, with its registere |
|
| June 14, 2023 |
Amendment to Amended and Restated Memorandum of Association and Articles of Association EXHIBIT 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman Healthcare AI Acquisition Corp. (ROC #371585) (the “Company”) TAKE NOTICE that by Minutes of the Extraordinary General Meeting held virtually on June 09, 2023, the following special resolution was passed: The Extension Amendment Proposal “RESOLVED, as a special resolution, THAT: The text |
|
| June 14, 2023 |
EXHIBIT 10.5 WARRANT EXCHANGE AGREEMENT This Warrant Exchange Agreement (this “Agreement”) is entered into as of June 14, 2023, by and between Healthcare AI Acquisition Corp., a Cayman Islands limited liability company (the “Company”), and Healthcare AI Acquisition LLC (the “Sponsor”). The parties to this Agreement are referred to herein as the “Parties” or, each individually, as a “Party.” Capita |
|
| June 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2023 (June 8, 2023) HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-41145 98-1585450 (State or other jurisdiction of |
|
| June 14, 2023 |
EXHIBIT 10.2 AMENDMENT TO THE LETTER AGREEMENT This AMENDMENT TO LETTER AGREEMENT (this “Amendment”), dated as of June 12, 2023, is entered into by and among Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), Healthcare AI Acquisition LLC (the “Sponsor”) and each of the undersigned (the “Insiders”). The Company, the Sponsor and the Insiders shall be referred to her |
|
| June 14, 2023 |
EXHIBIT 10.3 JOINDER TO LETTER AGREEMENT AND REGISTRATION RIGHTS AGREEMENT June 12, 2023 Reference is made to that certain Share Purchase Agreement, dated as of June 12, 2023 (the “Agreement”), by and among Atticus Ale, LLC (“Investor”), Healthcare AI Acquisition Corp. (the “Company”) and Healthcare AI Acquisition LLC (the “Sponsor”), pursuant to which Investor shall be entitled to acquire securit |
|
| June 14, 2023 |
EXHIBIT 10.6 INDEMNIFICATION LETTER AGREEMENT June 12, 2023 This Indemnification Letter Agreement (“Letter Agreement”), is made by and among Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”) and the Indemnitees whose names appear on the signature page hereto (the “Indemnitees”). WHEREAS, Reference is made to that certain Indemnity Agreement, dated as of December 14 |
|
| June 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| May 19, 2023 |
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 19, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. HEALTHCARE AI ACQUISITION CORP. (Ex |
|
| May 15, 2023 |
OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response 2. |
|
| March 31, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Healthcare AI Acquisition Corp. ( |
|
| March 31, 2023 |
Description of Registrant’s Securities. EX-4.2 Exhibit 4.2 HEALTHCARE AI ACQUISITION CORP. DESCRIPTION OF SECURITIES The following summary of the material terms of the securities of Healthcare AI Acquisition Corp. (“we,” “us,” “our” or “the company”) is not intended to be a complete summary of the rights and preferences of such securities and is subject to and qualified by reference to our amended and restated memorandum and articles of |
|
| March 31, 2023 |
Exhibit 21 LIST OF SUBSIDIARIES None. |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Healthcare AI Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) G4373K125 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 14, 2023 |
SC 13G/A 1 ea173493-13ga1cantorhealth.htm AMENDMENT NO. 1 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* Under the Securities Exchange Act of 1934 Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Titles of Class of Securities) G4373K109 (CUSIP Number) December 31, 2022 (Da |
|
| February 14, 2023 |
Joint Filing Agreement, dated as of February 14, 2023, by and among the Reporting Persons EX-99.1 2 ea173493ex99-1health.htm JOINT FILING AGREEMENT, DATED AS OF FEBRUARY 14, 2023, BY AND AMONG THE REPORTING PERSONS EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached as a |
|
| February 13, 2023 |
KYG4373K1094 / Healthcare AI Acquisition Corp. / ARISTEIA CAPITAL LLC Passive Investment SC 13G 1 sc13ghealthcareai.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. *) Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 (Title of Class of Securities) G4373K109 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Chec |
|
| February 2, 2023 |
SC 13G 1 p23-0470sc13g.htm HEALTHCARE AI ACQUISITION CORP SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value per share (Title of Class of Securities) G4373K109 (CUSIP Number) December 31, 2022 (Date of event which requires filin |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Titles of Class of Securities) G4373K109 (CUSIP Number) October 27, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 2, 2022 |
Joint Filing Agreement, dated as of November 2, 2022, by and among the Reporting Persons EX-99.1 2 ea167737ex99-1healthcareai.htm JOINT FILING AGREEMENT, DATED AS OF NOVEMBER 2, 2022, BY AND AMONG THE REPORTING PERSONS EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached |
|
| November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. HEALTHCARE AI ACQUISITION CORP. (Exact name of re |
|
| August 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. HEALTHCARE AI ACQUISITION CORP. (Exact name of registr |
|
| May 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . HEALTHCARE AI ACQUISITION CORP. (Exact name of regis |
|
| May 16, 2022 |
NT 10-Q 1 haia-nt10q20220331.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 001-41145 CUSIP Number: G4373K109 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20- |
|
| April 22, 2022 |
Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Continued Listing Standard Notice Exhibit 99.1 Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Continued Listing Standard Notice NEW YORK ? April 22, 2022 ? Healthcare AI Acquisition Corp. (Nasdaq: HAIA) (the ?Company?) today announced that on April 19, 2021 it received a deficiency letter from The Nasdaq Stock Market LLC (?Nasdaq?) relating to the Company?s failure to timely file its Annual Report on Form 10-K for the |
|
| April 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2022 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organizat |
|
| April 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Healthcare AI Acquisition Corp. (Exact name of regi |
|
| April 21, 2022 |
Description of Registrant’s Securities. Exhibit 4.2 HEALTHCARE AI ACQUISITION CORP. DESCRIPTION OF SECURITIES The following summary of the material terms of the securities of Healthcare AI Acquisition Corp. (“we,” “us,” “our” or “the company”) is not intended to be a complete summary of the rights and preferences of such securities and is subject to and qualified by reference to our amended and restated memorandum and articles of associ |
|
| April 21, 2022 |
Exhibit 21 LIST OF SUBSIDIARIES None. |
|
| April 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 001-41145 CUSIP Number: G4373K109 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? T |
|
| February 14, 2022 |
Saba Capital Management, L.P. - FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Healthcare AI Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) G4373K125 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| February 11, 2022 |
Healthcare AI Acquisition LLC - SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Healthcare AI Acquisition Corp. (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G4373K109 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the Appropriate Box to Designate the Rule Purs |
|
| January 31, 2022 |
EX-99.1 2 cik1848861-ex9916.htm EX-99.1 Exhibit 99.1 Healthcare AI Acquisition Corp. Announces Separate Trading of its Class A Ordinary Shares and Warrants Commencing January 31, 2022 Press Release LONDON, January 27, 2022 - Healthcare AI Acquisition Corp. (the “Company”), announced today that, commencing January 31, 2022, holders of the units sold in the Company’s public offering of 21,562,401 un |
|
| January 31, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2022 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organiz |
|
| December 22, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2021 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organi |
|
| December 22, 2021 |
HEALTHCARE AI ACQUISITION CORP. Index to Balance Sheet EX-99.1 2 cik1848861-ex9916.htm EX-99.1 Exhibit 99.1 HEALTHCARE AI ACQUISITION CORP. Index to Balance Sheet Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of December 14, 2021 F-3 Notes to Balance Sheet F-4 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Directors of Healthcare AI Acquisition Corp. Opinion on the Financial |
|
| December 20, 2021 |
Saba Capital Management, L.P. - FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Healthcare AI Acquisition Corp (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) G4373K125 (CUSIP Number) December 10, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| December 15, 2021 |
EX-10.3 7 cik1848861-ex1038.htm EX-10.3 Exhibit 10.3 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of December 14, 2021, is made and entered into by and among Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), Healthcare AI Acquisition, LLC, a Cayman Islands limited liability company (t |
|
| December 15, 2021 |
EX-10.2 6 cik1848861-ex1029.htm EX-10.2 Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of December 14, 2021 by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York Limited Purpose Trust Company (the “Trustee”). |
|
| December 15, 2021 |
Letter Agreement among the Registrant, the Sponsor and the Registrant’s officers and directors.(1) EX-10.4 8 cik1848861-ex1047.htm EX-10.4 Exhibit 10.4 December 14, 2021 Healthcare AI Acquisition Corp. 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands Re:Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Healthcare AI |
|
| December 15, 2021 |
Warrant Agreement between Continental Stock Transfer & Trust Company and the Company.(1) EX-4.1 4 cik1848861-ex4111.htm EX-4.1 Exhibit 4.1 WARRANT AGREEMENT HEALTHCARE AI ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this “Agreement”), dated December 14, 2021, is by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York Limited Purpose Trust Co |
|
| December 15, 2021 |
Administrative Services Agreement between the Registrant and the Sponsor.(1) EX-10.5 9 cik1848861-ex1056.htm EX-10.5 Exhibit 10.5 HEALTHCARE AI ACQUISITION CORP. 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands December 9, 2021 Healthcare AI Acquisition, LLC 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the day after the effective date (the "Effective Dat |
|
| December 15, 2021 |
Private Placement Warrants Purchase Agreement between the Company and the Sponsor.(1) EX-10.1 5 cik1848861-ex10110.htm EX-10.1 Exhibit 10.1 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of December 9, 2021, is entered into by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), |
|
| December 15, 2021 |
Amended and Restated Memorandum and Articles of Association.(1) EX-3.1 3 cik1848861-ex3112.htm EX-3.1 Exhibit 3.1 THE COMPANIES ACT (AS AMENDED) COMPANY LIMITED BY SHARES AMENDED AND RESTATED Memorandum OF association of Healthcare AI Acquisition Corp. (ADOPTED BY SPECIAL RESOLUTION DATED 8 December 2021) 1 THE COMPANIES act (AS AMENDED) COMPANY LIMITED BY SHARES amended and restated MEMORANDUM of ASSOCIATION OF Healthcare AI Acquisition Corp. (ADOPTED BY SPEC |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2021 HEALTHCARE AI ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organi |
|
| December 15, 2021 |
Underwriting Agreement among the Company and Citigroup Global Markets Inc. and Jefferies LLC Exhibit 1.1 Healthcare AI Acquisition Corp. 20,000,000 Units1 UNDERWRITING AGREEMENT New York, New York December 9, 2021 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Jefferies LLC 520 Madison Avenue New York, New York 10022 As Representatives of the several underwriters listed in Schedule I hereto (the “Underwriters”) Ladies and Gentlemen: Healthcare AI Acquisition C |
|
| December 13, 2021 |
Healthcare AI Acquisition Corp. 20,000,000 Units Filed pursuant to Rule 424(b)(4) Registration No. 333-261193 PROSPECTUS Healthcare AI Acquisition Corp. $200,000,000 20,000,000 Units Healthcare AI Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more busin |
|
| December 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 HEALTHCARE AI ACQUISITION CORP. |
|
| December 7, 2021 |
Healthcare AI Acquisition Corp. 190 Elgin Avenue George Town Grand Cayman KY1-9008 Cayman Islands December 7, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Sherry Haywood Re: Healthcare AI Acquisition Corp. Registration Statement on Form S-1 File No. 333-261193 Ms. Haywood: Pursuant to Rule 461 under the Secur |
|
| December 7, 2021 |
* * * [Signature Pages Follow] December 7, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| December 3, 2021 |
As filed with the U.S. Securities and Exchange Commission on December 3, 2021 under the Securities Act of 1933, as amended. No. 333-261193 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare AI Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 6770 98-1585450 (State |
|
| December 3, 2021 |
Healthcare AI Acquisition Corp. 190 Elgin Avenue George Town Grand Cayman KY1-9008 Cayman Islands December 3, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, D.C. 20549 Attn: Sherry Haywood Re: Healthcare AI Acquisition Corp. Registration Statement on Form S-1 Filed November 19, 2021 File No. 333-261193 Ms. H |
|
| November 19, 2021 |
Form of Amended and Restated Memorandum and Articles of Association.* Exhibit 3.2 THE COMPANIES ACT (AS AMENDED) COMPANY LIMITED BY SHARES AMENDED AND RESTATED Memorandum OF association of Healthcare AI Acquisition Corp. (ADOPTED BY SPECIAL RESOLUTION DATED ) 1 24509541.2 C7716.169187 THE COMPANIES act (AS AMENDED) COMPANY LIMITED BY SHARES amended and restated MEMORANDUM of ASSOCIATION OF Healthcare AI Acquisition Corp. (ADOPTED BY SPECIAL RESOLUTION DATED ) 1. The |
|
| November 19, 2021 |
Exhibit 10.8 [●], 2021 Healthcare AI Acquisition Corp. 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands Re:Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Healthcare AI Acquisition Corp., a Cayman Islands exempted com |
|
| November 19, 2021 |
Securities Subscription Agreement, dated February 23, 2021, between the Registrant and the Sponsor.* Exhibit 10.7 Healthcare AI Acquisition Corp. c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008 Cayman Islands February 23, 2021 Healthcare AI Acquisition, LLC c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008 Cayman Islands RE:Securities Subscription Agreement Ladies and Gentlemen: This agreement (this “Agreement”) is entered into |
|
| November 19, 2021 |
Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor.* EX-10.3 13 cik1848861-ex10318.htm EX-10.3 Exhibit 10.3 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of [●], 2021, is entered into by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and H |
|
| November 19, 2021 |
EX-10.1 11 cik1848861-ex10120.htm EX-10.1 Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2021 by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s r |
|
| November 19, 2021 |
Exhibit 99.3 CONSENT OF GREG CASWILL Healthcare AI Acquisition Corp., (the “Company”) intends to file a Registration Statement on Form S-l (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to bein |
|
| November 19, 2021 |
Exhibit 99.1 CONSENT OF XAVIER FLINOIS Healthcare AI Acquisition Corp., (the “Company”) intends to file a Registration Statement on Form S-l (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to be |
|
| November 19, 2021 |
Memorandum and Articles of Association.* EX-3.1 3 cik1848861-ex3127.htm EX-3.1 Exhibit 3.1 in the matter of THE Companies Act (AS AMENDED) and in the matter of Healthcare AI Acquisition Corp. DECLARATION I, Daniel Walford, of George Town, Grand Cayman, Cayman Islands, HEREBY DECLARE as follows: 1. WNL Limited is a Subscriber of Healthcare AI Acquisition Corp., a company applying for registration under the Companies Act (as amended). 2. T |
|
| November 19, 2021 |
Specimen Warrant Certificate.* EX-4.3 7 cik1848861-ex4323.htm EX-4.3 Exhibit 4.3 [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW Healthcare AI Acquisition Corp. Incorporated Under the Laws of the Cayman Islands CUSIP [•] Warrant Certificate This Warrant Certificate certifies that [ ], or registered assigns, is |
|
| November 19, 2021 |
EX-99.2 21 cik1848861-ex99210.htm EX-99.2 Exhibit 99.2 CONSENT OF ROBERT PICONI Healthcare AI Acquisition Corp., (the “Company”) intends to file a Registration Statement on Form S-l (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amend |
|
| November 19, 2021 |
As filed with the U.S. Securities and Exchange Commission on November 18, 2021 under the Securities Act of 1933, as amended. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare AI Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 6770 98-1585450 (State or o |
|
| November 19, 2021 |
Promissory Note, dated as of February 23, 2021, between the Registrant and the Sponsor.* Exhibit 10.6 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| November 19, 2021 |
Form of Underwriting Agreement.* EX-1.1 2 cik1848861-ex1129.htm EX-1.1 Exhibit 1.1 Healthcare AI Acquisition Corp. 20,000,000 Units1 UNDERWRITING AGREEMENT New York, New York [●], 2021 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Jefferies LLC 520 Madison Avenue New York, New York 10022 As Representatives of the several underwriters listed in Schedule I hereto (the “Underwriters”) Ladies and Gentlem |
|
| November 19, 2021 |
Exhibit 4.1 SPECIMEN UNIT CERTIFICATE NUMBER UNITS U- SEE REVERSE FOR CERTAIN Healthcare AI Acquisition Corp. DEFINITIONS CUSIP [ ] UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-HALF OF ONE REDEEMABLE WARRANT TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner ofUnits. Each Unit (“Unit”) consists of one (1) Class A ordinary share, par value $0.0001 per share (“Ordinary |
|
| November 19, 2021 |
Specimen Class A Ordinary Share Certificate.* EX-4.2 6 cik1848861-ex4224.htm EX-4.2 Exhibit 4.2 SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE NUMBER SHARES HEALTHCARE AI ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [ ] This Certifies thatis the owner of FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF US$0.0001 EACH OF HEALTHCARE AI |
|
| November 19, 2021 |
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.* Exhibit 4.4 WARRANT AGREEMENT HEALTHCARE AI ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this “Agreement”), dated [●], 2021, is by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”). |
|
| November 19, 2021 |
Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [●], 2021, by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and [●] (“Indemnitee”). WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with ad |
|
| November 19, 2021 |
Exhibit 10.2 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2021, is made and entered into by and among Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), Healthcare AI Acquisition, LLC, a Cayman Islands limited liability company (the “Sponsor”), and the undersigned parties liste |
|
| November 19, 2021 |
Consent of Elizabeth Weymouth.* Exhibit 99.4 CONSENT OF ELIZABETH WEYMOUTH Healthcare AI Acquisition Corp., (the “Company”) intends to file a Registration Statement on Form S-l (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents t |
|
| November 19, 2021 |
Form of Administrative Services Agreement between the Registrant and the Sponsor.* EX-10.5 15 cik1848861-ex10516.htm EX-10.5 Exhibit 10.5 HEALTHCARE AI ACQUISITION CORP. 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands [●], 2021 Healthcare AI Acquisition, LLC 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the day after the effective date (the "Effective Date") o |
|
| August 12, 2021 |
DRS/A 1 filename1.htm As confidentially submitted to the U.S. Securities and Exchange Commission on August 12, 2021. This draft registration statement has not been filed, publicly or otherwise, with the U.S. Securities and Exchange Commission and all information contained herein remains strictly confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMEN |
|
| June 7, 2021 |
DRS/A 1 filename1.htm As confidentially submitted to the U.S. Securities and Exchange Commission on June 4, 2021. This draft registration statement has not been filed, publicly or otherwise, with the U.S. Securities and Exchange Commission and all information contained herein remains strictly confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT N |
|
| May 28, 2021 |
SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE EX-4 6 filename6.htm Exhibit 4.2 SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE NUMBER SHARES HEALTHCARE AI ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [ ] This Certifies thatis the owner of FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF US$0.0001 EACH OF HEALTHCARE AI ACQUISITION CORP |
|
| May 28, 2021 |
As confidentially submitted to the U.S. Securities and Exchange Commission on May 28, 2021. This draft registration statement has not been filed, publicly or otherwise, with the U.S. Securities and Exchange Commission and all information contained herein remains strictly confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGIS |
|
| May 28, 2021 |
EX-10 18 filename18.htm Exhibit 10.8 [●], 2021 Healthcare AI Acquisition Corp. 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands Re:Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Healthcare AI Acquisition Corp., a Cay |
|
| May 28, 2021 |
REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT EX-10 12 filename12.htm Exhibit 10.2 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2021, is made and entered into by and among Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), Healthcare AI Acquisition, LLC, a Cayman Islands limited liability company (the “Sponsor”), and the u |
|
| May 28, 2021 |
Exhibit 3.2 THE COMPANIES ACT (AS AMENDED) COMPANY LIMITED BY SHARES AMENDED AND RESTATED Memorandum OF association of Healthcare AI Acquisition Corp. (ADOPTED BY SPECIAL RESOLUTION DATED ) 1 THE COMPANIES act (AS AMENDED) COMPANY LIMITED BY SHARES amended and restated MEMORANDUM of ASSOCIATION OF Healthcare AI Acquisition Corp. (ADOPTED BY SPECIAL RESOLUTION DATED ) 1. The name of the company is |
|
| May 28, 2021 |
Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of [?], 2021, by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and [?] (?Indemnitee?). WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with ad |
|
| May 28, 2021 |
Exhibit 4.3 [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW Healthcare AI Acquisition Corp. Incorporated Under the Laws of the Cayman Islands CUSIP [?] Warrant Certificate This Warrant Certificate certifies that [ ], or registered assigns, is the registered holder of [ ] warrant( |
|
| May 28, 2021 |
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT Exhibit 10.3 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), dated as of [?], 2021, is entered into by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Healthcare AI Acquisition, LLC, a Cayman Is |
|
| May 28, 2021 |
in the matter of THE Companies Act (AS AMENDED) in the matter Healthcare AI Acquisition Corp. EX-3 3 filename3.htm Exhibit 3.1 in the matter of THE Companies Act (AS AMENDED) and in the matter of Healthcare AI Acquisition Corp. DECLARATION I, Daniel Walford, of George Town, Grand Cayman, Cayman Islands, HEREBY DECLARE as follows: 1. WNL Limited is a Subscriber of Healthcare AI Acquisition Corp., a company applying for registration under the Companies Act (as amended). 2. The operation of t |
|
| May 28, 2021 |
EX-10 16 filename16.htm Exhibit 10.6 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND S |
|
| May 28, 2021 |
EX-10 17 filename17.htm Exhibit 10.7 Healthcare AI Acquisition Corp. c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008 Cayman Islands February 23, 2021 Healthcare AI Acquisition, LLC c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008 Cayman Islands RE:Securities Subscription Agreement Ladies and Gentlemen: This agreement (this “Agr |
|
| May 28, 2021 |
EX-4 5 filename5.htm Exhibit 4.1 SPECIMEN UNIT CERTIFICATE NUMBER UNITS U- SEE REVERSE FOR CERTAIN Healthcare AI Acquisition Corp. DEFINITIONS CUSIP [ ] UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-HALF OF ONE REDEEMABLE WARRANT TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner ofUnits. Each Unit (“Unit”) consists of one (1) Class A ordinary share, par value $0.0001 |
|
| May 28, 2021 |
WARRANT AGREEMENT HEALTHCARE AI ACQUISITION CORP. CONTINENTAL STOCK TRANSFER & TRUST COMPANY EX-4 8 filename8.htm Exhibit 4.4 WARRANT AGREEMENT HEALTHCARE AI ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this “Agreement”), dated [●], 2021, is by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, |
|
| May 28, 2021 |
EX-10 15 filename15.htm Exhibit 10.5 HEALTHCARE AI ACQUISITION CORP. 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands [●], 2021 Healthcare AI Acquisition, LLC 190 Elgin Avenue, George Town Grand Cayman KY1-9008 Cayman Islands Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the day after the effective date (the "Effective Date") of the registration |
|
| May 28, 2021 |
Healthcare AI Acquisition Corp. 25,000,000 Units1 UNDERWRITING AGREEMENT Exhibit 1.1 Healthcare AI Acquisition Corp. 25,000,000 Units1 UNDERWRITING AGREEMENT New York, New York [?], 2021 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Jefferies LLC 520 Madison Avenue New York, New York 10022 As Representatives of the several underwriters listed in Schedule I hereto (the ?Underwriters?) Ladies and Gentlemen: Healthcare AI Acquisition Corp., a |
|
| May 28, 2021 |
INVESTMENT MANAGEMENT TRUST AGREEMENT EX-10 11 filename11.htm Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2021 by and between Healthcare AI Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statem |
|
| March 19, 2021 |
DRS 1 filename1.htm As confidentially submitted to the U.S. Securities and Exchange Commission on March 19, 2021. This draft registration statement has not been filed, publicly or otherwise, with the U.S. Securities and Exchange Commission and all information contained herein remains strictly confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 RE |
